Table 1_Therapeutic potential of five frequently prescribed herbs in obesity-associated Hashimoto’s thyroiditis: insights from efferocytosis regulation.xlsx by Jiahao Zhou (11385383)

“…Moreover, TCM offers significant benefits in regulating lipid metabolism and decreasing systemic inflammation.…”

Table2_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table13_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table12_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table3_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table9_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Image1_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.tif by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table7_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table6_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table11_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table8_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table5_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table10_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table1_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Data sources and descriptions. by Zeduo Zou (21672789)

“…As the results show, during the study period: (1) Temporal Trends: annual PM2.5 concentrations exhibited significant declines, with BTH decreasing from 1004.71 μg/m³ (2006) to 528 μg/m³ (2020), YRD from 1434.81 μg/m³ (2008) to 621 μg/m³, and PRD from 405.02 μg/m³ (2007) to 292 μg/m³. …”

Table4_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Image2_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.tif by Yifang He (18126257)

“…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”

Table_1_Estimation of scrub typhus incidence and spatiotemporal multicomponent characteristics from 2016 to 2023 in Zhejiang Province, China.XLSX by Haocheng Wu (559031)

“…Background<p>China is one of the main epidemic areas of scrub typhus, and Zhejiang Province, which is located in the coastal area of southeastern China, is considered a key region of scrub typhus. However, there may be significant bias in the number of reported cases of scrub typhus, to the extent that its epidemiological patterns are not clearly understood. …”

Data Sheet 1_Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study.docx by Heinz Wiendl (237353)

“…IgG and IgM levels remained above the lower limits of normal in most participants. sNfL levels decreased, remaining reduced by M24. Significant reductions in the annualized combined unique active lesion count occurred from M2 onwards. …”

Data Sheet 2_Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study.csv by Heinz Wiendl (237353)

“…IgG and IgM levels remained above the lower limits of normal in most participants. sNfL levels decreased, remaining reduced by M24. Significant reductions in the annualized combined unique active lesion count occurred from M2 onwards. …”